In Canada, researchers with the Institute of Nutrition and Functional Foods at Laval University found that GlucoPhenol, a proprietary blend of cranberry and Orléans strawberry extracts, produced significant improvements in insulin sensitivity among non-diabetic, insulin-resistant adults. The findings suggest that the cranberry and strawberry polyphenols may increase both insulin signaling and the transport of glucose into skeletal muscle, thus improving insulin sensitivity.
“Our data indicate that GlucoPhenol may improve insulin sensitivity and prevent an increase in compensatory insulin secretion, representing a promising approach to improving glucose management in subjects at risk for type 2 diabetes,” explained team lead Hélène Jacques, PhD. “These results are particularly encouraging, as they indicate that polyphenols may delay or even halt the progression to type 2 diabetes.”
Part of a multi-year research collaboration between INAF and Atrium Innovations, GlucoPhenol from the study is now available under Atrium Innovations’ Pure Encapsulations, Douglas Laboratories and Genestra brands.